期刊文献+
共找到179,976篇文章
< 1 2 250 >
每页显示 20 50 100
Light-Activated Virtual Sensor Array with Machine Learning for Non-Invasive Diagnosis of Coronary Heart Disease
1
作者 Jiawang Hu Hao Qian +2 位作者 Sanyang Han Ping Zhang Yuan Lu 《Nano-Micro Letters》 SCIE EI CAS CSCD 2024年第12期427-448,共22页
Early non-invasive diagnosis of coronary heart disease(CHD)is critical.However,it is challenging to achieve accurate CHD diagnosis via detecting breath.In this work,heterostructured complexes of black phosphorus(BP)an... Early non-invasive diagnosis of coronary heart disease(CHD)is critical.However,it is challenging to achieve accurate CHD diagnosis via detecting breath.In this work,heterostructured complexes of black phosphorus(BP)and two-dimensional carbide and nitride(MXene)with high gas sensitivity and photo responsiveness were formulated using a self-assembly strategy.A light-activated virtual sensor array(LAVSA)based on BP/Ti_(3)C_(2)Tx was prepared under photomodulation and further assembled into an instant gas sensing platform(IGSP).In addition,a machine learning(ML)algorithm was introduced to help the IGSP detect and recognize the signals of breath samples to diagnose CHD.Due to the synergistic effect of BP and Ti_(3)C_(2)Tx as well as photo excitation,the synthesized heterostructured complexes exhibited higher performance than pristine Ti_(3)C_(2)Tx,with a response value 26%higher than that of pristine Ti_(3)C_(2)Tx.In addition,with the help of a pattern recognition algorithm,LAVSA successfully detected and identified 15 odor molecules affiliated with alcohols,ketones,aldehydes,esters,and acids.Meanwhile,with the assistance of ML,the IGSP achieved 69.2%accuracy in detecting the breath odor of 45 volunteers from healthy people and CHD patients.In conclusion,an immediate,low-cost,and accurate prototype was designed and fabricated for the noninvasive diagnosis of CHD,which provided a generalized solution for diagnosing other diseases and other more complex application scenarios. 展开更多
关键词 Black phosphorus/MXene heterostructures Light-activated virtual sensor array diagnosis of coronary heart disease Machine learning
下载PDF
Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer 被引量:14
2
作者 Antonio Rollan Catterina Ferreccio +3 位作者 Alessandra Gederlini Carolina Serrano Javiera Torres Paul Harris 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第44期7172-7178,共7页
AIM: To validate a non-invasive method to detect gastric mucosal atrophy in a Chilean population with high prevalence of gastric cancer and a poor survival rate. METHODS: We first determined the optimal cut-off level ... AIM: To validate a non-invasive method to detect gastric mucosal atrophy in a Chilean population with high prevalence of gastric cancer and a poor survival rate. METHODS: We first determined the optimal cut-off level of serum pepsinogen (PG)-1, PG-1/PG-2 ratio and 17-gastrin in 31 voluntary symptomatic patients (mean age: 66.1 years), of them 61% had histologically confirmed gastric atrophy. Then, in a population-based sample of 536 healthy individuals (209 residents in counties with higher relative risk and 327 residents in counties with lower relative risk for gastric cancer), we measured serum anti-H pylori antibodies, PG and 17-gastrin and estimated their risk of gastric cancer. RESULTS: We found that serum PG-1 < 61.5 μg/L, PG-1/PG-2 ratio < 2.2 and 17-gastrin > 13.3 pmol/L had a high specificity (91%-100%) and a fair sensitivity (56%-78%) to detect corpus-predominant atrophy. Based on low serum PG-1 and PG-1/PG-2 ratio together as diagnostic criteria, 12.5% of the asymptomatic subjects had corpus-predominant atrophy (0% of those under 25 years and 20.2% over 65 years old). The frequency of gastric atrophy was similar (12% vs 13%) but H pylori infection rate was slightly higher (77% vs 71%) in the high-risk compared to the low-risk counties. Based on their estimated gastric cancer risk, individuals were classified as: low-risk group (no H pylori infection and no atrophy; n = 115; 21.4%); moderate-risk group(H pylori infection but no atrophy; n = 354, 66.0%); and high-risk group (gastric atrophy, with or without H pylori infection; n = 67, 12.5%). The high-risk group was significantly older (mean age: 61.9 ± 13.3 years), more frequently men and less educated as compared with the low-risk group. CONCLUSION: We propose to concentrate on an upper gastrointestinal endoscopy for detection of early gastric cancer in the high-risk group. This intervention model could improve the poor prognosis of gastric cancer in Chile. 展开更多
关键词 Gastric cancer H pylori Gastric atrophy non-invasive diagnosis PEPSINOGEN GASTRIN
下载PDF
Acetone sensors for non-invasive diagnosis of diabetes based on metal-oxide-semiconductor materials 被引量:3
3
作者 Yujie Li Min Zhang Haiming Zhang 《Chinese Physics B》 SCIE EI CAS CSCD 2020年第9期156-163,共8页
In recent years, clinical studies have found that acetone concentration in exhaled breath can be taken as a characteristic marker of diabetes. Metal-oxide-semiconductor (MOS) materials are widely used in acetone gas s... In recent years, clinical studies have found that acetone concentration in exhaled breath can be taken as a characteristic marker of diabetes. Metal-oxide-semiconductor (MOS) materials are widely used in acetone gas sensors due to their low cost, high sensitivity, fast response/recovery time, and easy integration. This paper reviews recent progress in acetone sensors based on MOS materials for diabetes diagnosis. The methods of improving the performance of acetone sensor have been explored for comparison, especially in high humidity conditions. We summarize the current excellent methods of preparations of sensors based on MOSs and hope to provide some help for the progress of acetone sensors in the diagnosis of diabetes. 展开更多
关键词 non-invasive diabetes diagnosis acetone sensor SELECTIVE high humidity
下载PDF
Non-invasive diagnosis of liver fibrosis and cirrhosis 被引量:41
4
作者 Yoav Lurie Muriel Webb +2 位作者 Ruth Cytter-Kuint Shimon Shteingart Gerardo Z Lederkremer 《World Journal of Gastroenterology》 SCIE CAS 2015年第41期11567-11583,共17页
The evaluation and follow up of liver fibrosis and cirrhosis have been traditionally performed by liver biopsy. However, during the last 20 years, it has become evident that this "gold-standard" is imperfect... The evaluation and follow up of liver fibrosis and cirrhosis have been traditionally performed by liver biopsy. However, during the last 20 years, it has become evident that this "gold-standard" is imperfect; even according to its proponents, it is only "the best" among available methods. Attempts at uncovering non-invasive diagnostic tools have yielded multiple scores, formulae, and imaging modalities. All are better tolerated, safer, more acceptable to the patient, and can be repeated essentially as often as required. Most are much less expensive than liver biopsy. Consequently, their use is growing, and in some countries the number of biopsies performed, at least for routine evaluation of hepatitis B and C, has declined sharply. However, the accuracy and diagnostic value of most, if not all, of these methods remains controversial. In this review for the practicing physician, we analyze established and novel biomarkers and physical techniques. We may be witnessing in recent years the beginning of the end of the first phase for the development of non-invasive markers. Early evidence suggests that they might be at least as good as liver biopsy. Novel experimental markers and imaging techniques could produce a dramatic change in diagnosis in the near future. 展开更多
关键词 LIVER FIBROSIS CIRRHOSIS non-invasive SERUM biomar
下载PDF
Non-invasive diagnosis of alcoholic liver disease 被引量:16
5
作者 Sebastian Mueller Helmut Karl Seitz Vanessa Rausch 《World Journal of Gastroenterology》 SCIE CAS 2014年第40期14626-14641,共16页
Alcoholic liver disease(ALD)is the most common liver disease in the Western world.For many reasons,it isunderestimated and underdiagnosed.An early diagnosis is absolutely essential since it(1)helps to identify patient... Alcoholic liver disease(ALD)is the most common liver disease in the Western world.For many reasons,it isunderestimated and underdiagnosed.An early diagnosis is absolutely essential since it(1)helps to identify patients at genetic risk for ALD;(2)can trigger efficient abstinence namely in non-addicted patients;and(3)initiate screening programs to prevent life-threateningcomplications such as bleeding from varices,spontaneous bacterial peritonitis or hepatocellular cancer.The two major end points of ALD are alcoholic liver cirrhosis and the rare and clinically-defined alcoholic hepatitis(AH).The prediction and early diagnosis of both entities is still insufficiently solved and usually relies on acombination of laboratory,clinical and imaging findings.It is not widely conceived that conventional screeningtools for ALD such as ultrasound imaging or routine laboratory testing can easily overlook ca.40%of manifest alcoholic liver cirrhosis.Non-invasive methods such as transient elastography(Fibroscan),acoustic radiation force impulse imaging or shear wave elastography have significantly improved the early diagnosis of alcoholiccirrhosis.Present algorithms allow either the exclusion or the exact definition of advanced fibrosis stages in ca.95%of patients.The correct interpretation of liver stiffness requires a timely abdominal ultrasound and actual transaminase levels.Other non-invasive methods such as controlled attenuation parameter,serum levels of M30 or M65,susceptometry or breath tests are under current evaluation to assess the degree of steatosis,apoptosis and iron overload in these patients.Liver biopsy still remains an important option to rule out comorbidities and to confirm the prognosis namely for patients with AH. 展开更多
关键词 Alcoholic hepatitis Alcoholic steatohepatitis Alcoholic liver disease non-invasive Liver stiffness Serum marker STEATOSIS
下载PDF
Invasive and non-invasive diagnosis of cirrhosis and portal hypertension 被引量:14
6
作者 Moon Young Kim Woo Kyoung Jeong Soon Koo Baik 《World Journal of Gastroenterology》 SCIE CAS 2014年第15期4300-4315,共16页
With advances in the management and treatment of advanced liver disease,including the use of antiviral therapy,a simple,one stage description for advanced fibrotic liver disease has become inadequate.Although refining... With advances in the management and treatment of advanced liver disease,including the use of antiviral therapy,a simple,one stage description for advanced fibrotic liver disease has become inadequate.Although refining the diagnosis of cirrhosis to reflect disease heterogeneity is essential,current diagnostic tests have not kept pace with the progression of this new paradigm.Liver biopsy and hepatic venous pressure gradient measurement are the gold standards for the estimation of hepatic fibrosis and portal hypertension(PHT),respectively,and they have diagnostic and prognostic value.However,they are invasive and,as such,cannot be used repeatedly in clinical practice.The ideal noninvasive test should be safe,easy to perform,inexpensive,reproducible as well as to give numerical and accurate results in real time.It should be predictive of long term outcomes related with fibrosis and PHT to allow prognostic stratification.Recently,many types of noninvasive alternative tests have been developed and are under investigation.In particular,imaging and ultrasound based tests,such as transient elastography,have shown promising results.Although most of these noninvasive tests effectively identify severe fibrosis and PHT,the methods available for diagnosing moderate disease status are still insufficient,and further investigation is essential to predict outcomes and individualize therapy in this field. 展开更多
关键词 Hepatic fibrosis Portal hypertension Liver biopsy Hepatic venous pressure gradient non-invasive test Transient elastography
下载PDF
Non-invasive diagnosis of advanced fibrosis and cirrhosis 被引量:30
7
作者 Suraj Sharma Korosh Khalili Geoffrey Christopher Nguyen 《World Journal of Gastroenterology》 SCIE CAS 2014年第45期16820-16830,共11页
Liver cirrhosis is a common and growing public health problem globally.The diagnosis of cirrhosis portends an increased risk of morbidity and mortality.Liver biopsy is considered the gold standard for diagnosis of cir... Liver cirrhosis is a common and growing public health problem globally.The diagnosis of cirrhosis portends an increased risk of morbidity and mortality.Liver biopsy is considered the gold standard for diagnosis of cirrhosis and staging of fibrosis.However,despite its universal use,liver biopsy is an invasive and inaccurate gold standard with numerous drawbacks.In order to overcome the limitations of liver biopsy,a number of non-invasive techniques have been investigated for the assessment of cirrhosis.This review will focus on currently available non-invasive markers of cirrhosis.The evidence behind the use of these markers will be highlighted,along with an assessment of diagnostic accuracy and performance characteristics of each test.Non-invasive markers of cirrhosis can be radiologic or serum-based.Radiologic techniques based on ultrasound,magnetic resonance imaging and elastography have been used to assess liver fibrosis.Serum-based biomarkers of cirrhosis have also been developed.These are broadly classified into indirect and direct markers.Indirect biomarkers reflect liver function,which may decline with the onset of cirrhosis.Direct biomarkers,reflect extracellular matrix turnover,and include molecules involved in hepatic fibrogenesis.On the whole,radiologic and serum markers of fibrosis correlate well with biopsy scores,especially when excluding cirrhosis or excluding fibrosis.This feature is certainly clinically useful,and avoids liver biopsy in many cases. 展开更多
关键词 CIRRHOSIS Biomarker non-invasive FIBROSIS VIRAL Non-alcoholic fatty liver disease Primary biliary cirrhosis Autoimmune hepatitis Hepatitis B virus Hepatitis C virus
下载PDF
Non-invasive diagnosis of liver fibrosis in chronic hepatitis C 被引量:11
8
作者 Leonardo de Lucca Schiavon Janaína Luz Narciso-Schiavon Roberto José de Carvalho-Filho 《World Journal of Gastroenterology》 SCIE CAS 2014年第11期2854-2866,共13页
Assessment of liver fibrosis in chronic hepatitis C virus(HCV)infection is considered a relevant part of patient care and key for decision making.Although liver biopsy has been considered the gold standard for staging... Assessment of liver fibrosis in chronic hepatitis C virus(HCV)infection is considered a relevant part of patient care and key for decision making.Although liver biopsy has been considered the gold standard for staging liver fibrosis,it is an invasive technique and subject to sampling errors and significant intra-and inter-observer variability.Over the last decade,several noninvasive markers were proposed for liver fibrosis diagnosis in chronic HCV infection,with variable performance.Besides the clear advantage of being noninvasive,a more objective interpretation of test results may overcome the mentioned intra-and inter-observer variability of liver biopsy.In addition,these tests can theoretically offer a more accurate view of fibrogenic events occurring in the entire liver with the advantage of providing frequent fibrosis evaluation without additional risk.However,in general,these tests show low accuracy in discriminating between intermediate stages of fibrosis and may be influenced by several hepatic and extrahepatic conditions.These methods are either serum markers(usually combined in a mathematical model)or imaging modalities that can be used separately or combined in algorithms to improve accuracy.In this review we will discuss the different noninvasive methods that are currently available for the evaluation of liver fibrosis in chronic hepatitis C,their advantages,limitations and application in clinical practice. 展开更多
关键词 Liver fibrosis Liver cirrhosis Hepatitis C diagnosis Elasticity imaging techniques
下载PDF
Non-invasive diagnosis of Crohn’s disease:All that glitters is not gold
9
作者 Mohammed Khorshid Mohammad Abdel Khalik Elkady +1 位作者 Rana Abdelkarim Mohamed El-Nady 《World Journal of Meta-Analysis》 2021年第1期40-44,共5页
Crohn’s disease(CD)is associated with occurrence of inflammation in the digestive tract.Diagnosing intestinal bowel diseases can be difficult because bowel disease can be tricky as it does not have unique symptoms.En... Crohn’s disease(CD)is associated with occurrence of inflammation in the digestive tract.Diagnosing intestinal bowel diseases can be difficult because bowel disease can be tricky as it does not have unique symptoms.Endoscopy and histopathological tests play a crucial role in the diagnosis and management of inflammatory bowel diseases.Various techniques can be used to diagnose CD.Nevertheless,the diagnosis of CD mostly requires having patients in the hospital.During the SARS-CoV-2 pandemic,that might not be very feasible,as minimizing contact is essential,but can an alternative diagnosis technique be enough to provide a definitive diagnosis? 展开更多
关键词 Crohn’s disease Inflammatory bowel disease diagnosis NONINVASIVE HISTOPATHOLOGY OVERdiagnosis
下载PDF
The role of cell-free DNA in non-invasive diagnosis of urinary tract infection
10
作者 Yu Zhao Wenhui Zhang +1 位作者 Yina Ma Xin Zhang 《UroPrecision》 2024年第2期41-50,共10页
Urinary tract infection(UTI)constitutes a pervasive health concern.UTIs are dichotomously classified into upper and lower strata,and further categorized as either complicated or uncomplicated.Upper UTIs predominantly ... Urinary tract infection(UTI)constitutes a pervasive health concern.UTIs are dichotomously classified into upper and lower strata,and further categorized as either complicated or uncomplicated.Upper UTIs predominantly afflict the renal and ureteral domains,typified by conditions exemplified in pyelonephritis,whereas lower UTIs manifest within the confines of the urethra and bladder.The conventional diagnosis of UTIs relies upon clinical manifestations and urine culture.Common symptoms encompass dysuria,frequent micturition,hematuria,and suprapubic discomfort.Urine culture serves to identify the specific pathogens instigating the infection and assess their antibiotic susceptibility.However,this procedural protocol generally necessitates an approximate duration of 24 h,coupled with an additional 24-h interval for antibiotic susceptibility testing.In contradistinction,the detection of cell-free DNA(cfDNA)in the circulatory system presents a potential avenue for non-invasive diagnostic modalities.Notwithstanding,cfDNA emanates from deteriorating cells,affording insights into the extant cellular demise within the organism.Extensive scholarly inquiry has established a positive correlation between cfDNA concentration in the bloodstream and the incidence of cell death in conditions,such as severe traumas,sepsis,aseptic inflammation,myocardial infarction,and stroke.However,limited investigative effort has been devoted to elucidating the diagnostic potential of cfDNA in the context of UTIs.Consequently,the concentration and constitution of plasma cfDNA harbor substantial promise for non-invasively diagnosing UTIs.In summation,the utilization of cfDNA in UTI diagnosis remains an incipient area of scholarly pursuit,underscoring the imperative for further research to elucidate the prospective role of plasma cfDNA in non-intrusively discerning UTIs. 展开更多
关键词 cell-free DNA diagnosis DNA methylation urinary tract infection
原文传递
Variability in fecal metabolome depending on age, PFBS pollutant, and fecal transplantation in zebrafish: A non-invasive diagnosis of health 被引量:1
11
作者 Baili Sun Mengyuan Liu +3 位作者 Lizhu Tang Xiangzhen Zhou Chenyan Hu Lianguo Chen 《Journal of Environmental Sciences》 SCIE EI CAS CSCD 2023年第5期530-540,共11页
To protect the wellbeing of research animals,certain non-invasive measures are in increasing need to facilitate an early diagnosis of health and toxicity.In this study,feces specimen was collected from adult zebrafish... To protect the wellbeing of research animals,certain non-invasive measures are in increasing need to facilitate an early diagnosis of health and toxicity.In this study,feces specimen was collected from adult zebrafish to profile the metabolome fingerprint.Variability in fecal metabolite composition was also distinguished as a result of aging,perfluorobutanesulfonate(PFBS)toxicant,and fecal transplantation.The results showed that zebrafish feces was very rich in a diversity of metabolites that belonged to several major classes,including lipid,amino acid,carbohydrate,vitamin,steroid hormone,and neurotransmitter.Fecal metabolites had functional implications to multiple physiological activities,which were characterized by the enrichment of digestion,absorption,endocrine,and neurotransmission processes.The high richness and functional involvement of fecal metabolites pinpointed feces as an abundant source of diagnostic markers.By comparison between young and aged zebrafish,fundamental modifications of fecal metabolomes were caused by aging progression,centering on the neuroactive ligand-receptor interaction pathway.Exposure of aged zebrafish to PFBS pollutant also significantly disrupted the metabolomic structure in feces.Of special concern were the changes in fecal hormone intermediates after PFBS exposure,which was concordant with the in vivo endocrine disrupting effects of PFBS.Furthermore,itwas intriguing that transplantation of young zebrafish feces efficientlymitigated the metabolic perturbation of PFBS in aged recipients,highlighting the health benefits of therapeutic strategies based on gut microbiota manipulation.In summary,the present study provides preliminary clues to evidence the non-invasive advantage of fecal metabolomics in the early diagnosis and prediction of physiology and toxicology. 展开更多
关键词 Fecal metabolome Aging microbiota Perfluorobutanesulfonate(PFBS) Fecal transplantation non-invasive diagnosis ZEBRAFISH
原文传递
FibroScan-aspartate transaminase:A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis 被引量:1
12
作者 Jing-Ya Yin Tian-Yuan Yang +4 位作者 Bing-Qing Yang Chen-Xue Hou Jun-Nan Li Yue Li Qi Wang 《World Journal of Gastroenterology》 SCIE CAS 2024年第18期2440-2453,共14页
BACKGROUND Non-alcoholic fatty liver disease(NAFLD)with hepatic histological NAFLD activity score≥4 and fibrosis stage F≥2 is regarded as“at risk”non-alcoholic steatohepatitis(NASH).Based on an international conse... BACKGROUND Non-alcoholic fatty liver disease(NAFLD)with hepatic histological NAFLD activity score≥4 and fibrosis stage F≥2 is regarded as“at risk”non-alcoholic steatohepatitis(NASH).Based on an international consensus,NAFLD and NASH were renamed as metabolic dysfunction-associated steatotic liver disease(MASLD)and metabolic dysfunction-associated steatohepatitis(MASH),respectively;hence,we introduced the term“high-risk MASH”.Diagnostic values of seven non-invasive models,including FibroScan-aspartate transaminase(FAST),fibrosis-4(FIB-4),aspartate transaminase to platelet ratio index(APRI),etc.for high-risk MASH have rarely been studied and compared in MASLD.AIM To assess the clinical value of seven non-invasive models as alternatives to liver biopsy for diagnosing high-risk MASH.METHODS A retrospective analysis was conducted on 309 patients diagnosed with NAFLD via liver biopsy at Beijing Ditan Hospital,between January 2012 and December 2020.After screening for MASLD and the exclusion criteria,279 patients wereincluded and categorized into high-risk and non-high-risk MASH groups.Utilizing threshold values of each model,sensitivity,specificity,positive predictive value(PPV),and negative predictive values(NPV),were calculated.Receiver operating characteristic curves were constructed to evaluate their diagnostic efficacy based on the area under the curve(AUROC).RESULTS MASLD diagnostic criteria were met by 99.4%patients with NAFLD.The MASLD population was analyzed in two cohorts:Overall population(279 patients)and the subgroup(117 patients)who underwent liver transient elastography(FibroScan).In the overall population,FIB-4 showed better diagnostic efficacy and higher PPV,with sensitivity,specificity,PPV,NPV,and AUROC of 26.9%,95.2%,73.5%,72.2%,and 0.75.APRI,Forns index,and aspartate transaminase to alanine transaminase ratio(ARR)showed moderate diagnostic efficacy,whereas S index and gamma-glutamyl transpeptidase to platelet ratio(GPR)were relatively weaker.In the subgroup,FAST had the highest diagnostic efficacy,its sensitivity,specificity,PPV,NPV,and AUROC were 44.2%,92.3%,82.1%,67.4%,and 0.82.The FIB-4 AUROC was 0.76.S index and GPR exhibited almost no diagnostic value for high-risk MASH.CONCLUSION FAST and FIB-4 could replace liver biopsy as more effectively diagnostic methods for high-risk MASH compared to APRI,Forns index,ARR,S index,and GPR;FAST is superior to FIB-4. 展开更多
关键词 Metabolic dysfunction-associated steatotic liver disease High-risk metabolic dysfunction-associated steatohepatitis non-invasive models Liver biopsy Diagnostic value
下载PDF
Non-Invasive Approach to Early Diagnosis of the Formation of Oncological Neoplasms
13
作者 Rafik Sargsyan Gagik Karamyan +2 位作者 Luiza Simonyan Armen Manukyan Vahram Sargsyan 《Journal of Cancer Therapy》 CAS 2023年第4期202-210,共9页
The currently developed instrumental approaches for detecting pathological changes in the body have a number of disadvantages. The most important of them is that the equipment is sensitive to the detection of diseases... The currently developed instrumental approaches for detecting pathological changes in the body have a number of disadvantages. The most important of them is that the equipment is sensitive to the detection of diseases only from a certain threshold level of destructive changes in the body. The present article discusses the possibility of using the new instrumental complex “Bioscope” for early and non-invasive diagnosis of the beginning of the formation of ontological neoplasm’s in the body. 展开更多
关键词 Cancer Early non-invasive Diagnostic Bioscope
下载PDF
Non-invasively differentiate non-alcoholic steatohepatitis by visualizing hepatic integrinαvβ3 expression with a targeted molecular imaging modality
14
作者 Xiao-Quan Huang Ling Wu +7 位作者 Chun-Yan Xue Chen-Yi Rao Qing-Qing Fang Ying Chen Cao Xie Sheng-Xiang Rao Shi-Yao Chen Feng Li 《World Journal of Hepatology》 2024年第11期1290-1305,共16页
BACKGROUND Non-invasive methods to diagnose non-alcoholic steatohepatitis(NASH),an inflammatory subtype of non-alcoholic fatty liver disease(NAFLD),are currently unavailable.AIM To develop an integrinαvβ3-targeted m... BACKGROUND Non-invasive methods to diagnose non-alcoholic steatohepatitis(NASH),an inflammatory subtype of non-alcoholic fatty liver disease(NAFLD),are currently unavailable.AIM To develop an integrinαvβ3-targeted molecular imaging modality to differentiate NASH.METHODS Integrinαvβ3 expression was assessed in Human LO2 hepatocytes Scultured with palmitic and oleic acids(FFA).Hepatic integrinαvβ3 expression was analyzed in rabbits fed a high-fat diet(HFD)and in rats fed a high-fat,high-carbohydrate diet(HFCD).After synthesis,cyclic arginine-glycine-aspartic acid peptide(cRGD)was labeled with gadolinium(Gd)and used as a contrast agent in magnetic resonance imaging(MRI)performed on mice fed with HFCD.RESULTS Integrinαvβ3 was markedly expressed on FFA-cultured hepatocytes,unlike the control hepatocytes.Hepatic integrinαvβ3 expression significantly increased in both HFD-fed rabbits and HFCD-fed rats as simple fatty liver(FL)progressed to steatohepatitis.The distribution of integrinαvβ3 in the liver of NASH cases largely overlapped with albumin-positive staining areas.In comparison to mice with simple FL,the relative liver MRI-T1 signal value at 60 minutes post-injection of Gd-labeled cRGD was significantly increased in mice with steatohepatitis(P<0.05),showing a positive correlation with the NAFLD activity score(r=0.945;P<0.01).Hepatic integrinαvβ3 expression was significantly upregulated during NASH development,with hepatocytes being the primary cells expressing integrinαvβ3.CONCLUSION After using Gd-labeled cRGD as a tracer,NASH was successfully distinguished by visualizing hepatic integrinαvβ3 expression with MRI. 展开更多
关键词 Non-alcoholic steatohepatitis Cyclic peptides Magnetic resonance imaging non-invasive diagnosis Hepatic integrinαvβ3
下载PDF
Stage at diagnosis of colorectal cancer through diagnostic route:Who should be screened? 被引量:10
15
作者 Nobukazu Agatsuma Takahiro Utsumi +11 位作者 Yoshitaka Nishikawa Takahiro Horimatsu Takeshi Seta Yukitaka Yamashita Yukari Tanaka Takahiro Inoue Yuki Nakanishi Takahiro Shimizu Mikako Ohno Akane Fukushima Takeo Nakayama Hiroshi Seno 《World Journal of Gastroenterology》 SCIE CAS 2024年第10期1368-1376,共9页
BACKGROUND Colorectal cancer(CRC)is a global health concern,with advanced-stage diagnoses contributing to poor prognoses.The efficacy of CRC screening has been well-established;nevertheless,a significant proportion of... BACKGROUND Colorectal cancer(CRC)is a global health concern,with advanced-stage diagnoses contributing to poor prognoses.The efficacy of CRC screening has been well-established;nevertheless,a significant proportion of patients remain unscreened,with>70%of cases diagnosed outside screening.Although identifying specific subgroups for whom CRC screening should be particularly recommended is crucial owing to limited resources,the association between the diagnostic routes and identification of these subgroups has been less appreciated.In the Japanese cancer registry,the diagnostic routes for groups discovered outside of screening are primarily categorized into those with comorbidities found during hospital visits and those with CRC-related symptoms.AIM To clarify the stage at CRC diagnosis based on diagnostic routes.METHODS We conducted a retrospective observational study using a cancer registry of patients with CRC between January 2016 and December 2019 at two hospitals.The diagnostic routes were primarily classified into three groups:Cancer screening,follow-up,and symptomatic.The early-stage was defined as Stages 0 or I.Multivariate and univariate logistic regressions were exploited to determine the odds of early-stage diagnosis in the symptomatic and cancer screening groups,referencing the follow-up group.The adjusted covariates were age,sex,and tumor location.RESULTS Of the 2083 patients,715(34.4%),1064(51.1%),and 304(14.6%)belonged to the follow-up,symptomatic,and cancer screening groups,respectively.Among the 2083 patients,CRCs diagnosed at an early stage were 57.3%(410 of 715),23.9%(254 of 1064),and 59.5%(181 of 304)in the follow-up,symptomatic,and cancer screening groups,respectively.The symptomatic group exhibited a lower likelihood of early-stage diagnosis than the follow-up group[P<0.001,adjusted odds ratio(aOR),0.23;95%confidence interval(95%CI):0.19-0.29].The likelihood of diagnosis at an early stage was similar between the follow-up and cancer screening groups(P=0.493,aOR for early-stage diagnosis in the cancer screening group vs follow-up group=1.11;95%CI=0.82-1.49).CONCLUSION CRCs detected during hospital visits for comorbidities were diagnosed earlier,similar to cancer screening.CRC screening should be recommended,particularly for patients without periodical hospital visits for comorbidities. 展开更多
关键词 Colorectal neoplasms Cancer registry Diagnostic route Cancer screening Stage at diagnosis
下载PDF
Value of procalcitonin and presepsin in the diagnosis and severity stratification of sepsis and septic shock 被引量:2
16
作者 Enfeng Ren Hongli Xiao +3 位作者 Guoxing Wang Yongzhen Zhao Han Yu Chunsheng Li 《World Journal of Emergency Medicine》 SCIE CAS CSCD 2024年第2期135-138,共4页
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection.[1,2]Septic shock,the most severe form of sepsis,is characterized by circulatory and cellular/metabolic abnor... Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection.[1,2]Septic shock,the most severe form of sepsis,is characterized by circulatory and cellular/metabolic abnormalities,and can increase mortality to>40%.[1-3]Early recognition and risk stratification of septic shock are crucial but challenging because of the heterogeneity of its presentation and progression. 展开更多
关键词 diagnosis SEPSIS MORTALITY
下载PDF
Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts 被引量:3
17
作者 Zhen Song Qi Zhou +2 位作者 Jiang-Lei Zhang Jun Ouyang Zhi-Yu Zhang 《World Journal of Clinical Cases》 SCIE 2024年第1期32-41,共10页
BACKGROUND Prostate cancer(PCa)is a widespread malignancy,predominantly affecting elderly males,and current methods for diagnosis and treatment of this disease continue to fall short.The marker Ki-67(MKI67)has been pr... BACKGROUND Prostate cancer(PCa)is a widespread malignancy,predominantly affecting elderly males,and current methods for diagnosis and treatment of this disease continue to fall short.The marker Ki-67(MKI67)has been previously demonstrated to correlate with the proliferation and metastasis of various cancer cells,including those of PCa.Hence,verifying the association between MKI67 and the diagnosis and prognosis of PCa,using bioinformatics databases and clinical data analysis,carries significant clinical implications.AIM To explore the diagnostic and prognostic efficacy of antigens identified by MKI67 expression in PCa.METHODS For cohort 1,the efficacy of MKI67 diagnosis was evaluated using data from The Cancer Genome Atlas(TCGA)and Genotype-Tissue Expression(GTEx)databases.For cohort 2,the diagnostic and prognostic power of MKI67 expression was further validated using data from 271 patients with clinical PCa.RESULTS In cohort 1,MKI67 expression was correlated with prostate-specific antigen(PSA),Gleason Score,T stage,and N stage.The receiver operating characteristic(ROC)curve showed a strong diagnostic ability,and the Kaplan-Meier method demonstrated that MKI67 expression was negatively associated with the progression-free interval(PFI).The time-ROC curve displayed a weak prognostic capability for MKI67 expression in PCa.In cohort 2,MKI67 expression was significantly related to the Gleason Score,T stage,and N stage;however,it was negatively associated with the PFI.The time-ROC curve revealed the stronger prognostic capability of MKI67 in patients with PCa.Multivariate COX regression analysis was performed to select risk factors,including PSA level,N stage,and MKI67 expression.A nomogram was established to predict the 3-year PFI.CONCLUSION MKI67 expression was positively associated with the Gleason Score,T stage,and N stage and showed a strong diagnostic and prognostic ability in PCa. 展开更多
关键词 Marker Ki-67 Prostate cancer BIOMARKER diagnosis PROGNOSIS
下载PDF
Dynamic Vision Enabled Contactless Cross-Domain Machine Fault Diagnosis With Neuromorphic Computing 被引量:1
18
作者 Xinrui Chen Xiang Li +3 位作者 Shupeng Yu Yaguo Lei Naipeng Li Bin Yang 《IEEE/CAA Journal of Automatica Sinica》 SCIE EI CSCD 2024年第3期788-790,共3页
Dear Editor,This letter presents a novel dynamic vision enabled contactless cross-domain fault diagnosis method with neuromorphic computing.The event-based camera is adopted to capture the machine vibration states in ... Dear Editor,This letter presents a novel dynamic vision enabled contactless cross-domain fault diagnosis method with neuromorphic computing.The event-based camera is adopted to capture the machine vibration states in the perspective of vision. 展开更多
关键词 FAULT LESS diagnosis
下载PDF
Functional near-infrared spectroscopy in non-invasive neuromodulation 被引量:3
19
作者 Congcong Huo Gongcheng Xu +6 位作者 Hui Xie Tiandi Chen Guangjian Shao Jue Wang Wenhao Li Daifa Wang Zengyong Li 《Neural Regeneration Research》 SCIE CAS CSCD 2024年第7期1517-1522,共6页
Non-invasive cerebral neuromodulation technologies are essential for the reorganization of cerebral neural networks,which have been widely applied in the field of central neurological diseases,such as stroke,Parkinson... Non-invasive cerebral neuromodulation technologies are essential for the reorganization of cerebral neural networks,which have been widely applied in the field of central neurological diseases,such as stroke,Parkinson’s disease,and mental disorders.Although significant advances have been made in neuromodulation technologies,the identification of optimal neurostimulation paramete rs including the co rtical target,duration,and inhibition or excitation pattern is still limited due to the lack of guidance for neural circuits.Moreove r,the neural mechanism unde rlying neuromodulation for improved behavioral performance remains poorly understood.Recently,advancements in neuroimaging have provided insight into neuromodulation techniques.Functional near-infrared spectroscopy,as a novel non-invasive optical brain imaging method,can detect brain activity by measuring cerebral hemodynamics with the advantages of portability,high motion tole rance,and anti-electromagnetic interference.Coupling functional near-infra red spectroscopy with neuromodulation technologies offe rs an opportunity to monitor the cortical response,provide realtime feedbac k,and establish a closed-loop strategy integrating evaluation,feedbac k,and intervention for neurostimulation,which provides a theoretical basis for development of individualized precise neuro rehabilitation.We aimed to summarize the advantages of functional near-infra red spectroscopy and provide an ove rview of the current research on functional near-infrared spectroscopy in transcranial magnetic stimulation,transcranial electrical stimulation,neurofeedback,and braincomputer interfaces.Furthermore,the future perspectives and directions for the application of functional near-infrared spectroscopy in neuromodulation are summarized.In conclusion,functional near-infrared spectroscopy combined with neuromodulation may promote the optimization of central pellral reorganization to achieve better functional recovery form central nervous system diseases. 展开更多
关键词 brain-computer interface cerebral neural networks functional near-infrared spectroscopy neural circuit NEUROFEEDBACK neurological diseases NEUROMODULATION non-invasive brain stimulation transcranial electrical stimulation transcranial electrical stimulation
下载PDF
Handheld bedside ultrasound in the diagnosis of myocarditis 被引量:1
20
作者 Frank Wheeler Robin Lahr +2 位作者 James Espinosa Alan Lucerna Henry Schuitema 《World Journal of Emergency Medicine》 SCIE CAS CSCD 2024年第1期73-74,共2页
Myocarditis is a disease process that every emergency physician fears missing.Its severity can be mild to life-threatening,and many cases are likely undetected because they are subclinical with nonspecifi c signs.[1]S... Myocarditis is a disease process that every emergency physician fears missing.Its severity can be mild to life-threatening,and many cases are likely undetected because they are subclinical with nonspecifi c signs.[1]Subtle cardiac signs may be overshadowed by systemic symptoms of the underlying infectious process.Fever,myalgias,lethargy,symptoms commonly associated with viral syndrome,can mask the life-threatening myocarditis that may be present.In fact,in the United States Myocarditis Treatment Trial,almost 90%of patients reported symptoms consistent with a viral prodrome.[2]Ammirati et al[3]reported that 27%of patients with myocarditis had either reduced left ventricular ejection fraction,ventricular arrhythmias,or low cardiac output.Here,we present a case report,in which handheld point-of-care ultrasound was utilized at the bedside to aid in the critical diagnosis of myocarditis.With the additional information provided through this imaging modality,this patient was able to be transferred to the appropriate tertiary care facility in an expeditious manner and receive possible defi nitive treatment. 展开更多
关键词 diagnosis MYOCARDITIS FEVER
下载PDF
上一页 1 2 250 下一页 到第
使用帮助 返回顶部